Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues

Until now, the Food and Drug Administration (FDA)-approved iron supplement ferumoxytol and other iron oxide nanoparticles have been used for treating iron deficiency, as contrast agents for magnetic resonance imaging and as drug carriers. Here, we show an intrinsic therapeutic effect of ferumoxytol...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nat Nanotechnol
Main Authors: Zanganeh, Saeid, Hutter, Gregor, Spitler, Ryan, Lenkov, Olga, Mahmoudi, Morteza, Shaw, Aubie, Pajarinen, Jukka Sakari, Nejadnik, Hossein, Goodman, Stuart, Moseley, Michael, Coussens, Lisa Marie, Daldrup-Link, Heike Elisabeth
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5198777/
https://ncbi.nlm.nih.gov/pubmed/27668795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nnano.2016.168
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados